Barely Significant
← all excerpts

Efficacy and safety of immune checkpoint inhibitors in the treatment of recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis.

Chin Med J (Engl) · 2025 · PMC11882294 · PMID 39602325

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

borderline significanceP = 0.07so close (0.05 < p ≤ 0.1)
Heterogeneity was found in these analyses across the included trials, with one showing borderline significance (ORR: I 2 = 41%, P = 0.07; DCR: I 2 = 67%, P <0.01; PFS: I 2 = 83%, P <0.01), and random models were applied.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.